Solutions for Drama-Free mAb Development

Overview

Therapeutic monoclonal antibodies (mAbs) are produced via a laborious multi-step process involving cell line development (CLD), antibody isolation and purification, and extensive testing.

Although this approach is effective, as evidenced by the number of mAb therapeutics that have been commercialized, it has a high risk of failure and is often unsuitable for poorly immunogenic targets. As a result, researchers are choosing to incorporate state-of-the-art technologies for rapid identification, characterization and purification of candidate molecules into mAb development workflows, to increase their chances of discovering the next novel drug.

Read this article to learn how Sartoclear Dynamics^® Lab kits can revolutionize your cell culture clarification and filtration process.

• Document type: Article
• Page count: 4
• Read time: 8 minutes

Complete the Form to Access the Article